Keloid Scarring: Understanding the Genetic Basis, Advances, and Prospects

 

 Permissions and Reprints

Keloid disease is a fibroproliferative dermal tumor with an unknown etiology that occurs after a skin injury in genetically susceptible individuals. Increased familial aggregation, a higher prevalence in certain races, parallelism in identical twins, and alteration in gene expression all favor a remarkable genetic contribution to keloid pathology. It seems that the environment triggers the disease in genetically susceptible individuals. Several genes have been implicated in the etiology of keloid disease, but no single gene mutation has thus far been found to be responsible. Therefore, a combination of methods such as association, gene-gene interaction, epigenetics, linkage, gene expression, and protein analysis should be applied to determine keloid etiology.

This study was supported by a Universiti Sains Malaysia (USM) short-term grant (No. 304/PPSP/61310017).

Publication History

Received: 08 February 2012

Accepted: 15 February 2012

Article published online:
01 May 2022

© 2012. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

• REFERENCES

• 1 Kelly AP. Medical and surgical therapies for keloids. Dermatol Ther 2004; 17: 212-218
  CrossrefPubMedGoogle Scholar
• 2 Kelly AP. Keloids. Dermatol Clin 1988; 6: 413-424
  CrossrefPubMedGoogle Scholar
• 3 Child FJ, Fuller LC, Higgins EM. et al. A study of the spectrum of skin disease occurring in a black population in south-east London. Br J Dermatol 1999; 141: 512-517
  CrossrefPubMedGoogle Scholar
• 4 Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol 2002; 46: S63-S97
  CrossrefPubMedGoogle Scholar
• 5 Marneros AG, Norris JE, Olsen BR. et al. Clinical genetics of familial keloids. Arch Dermatol 2001; 137: 1429-1434
  PubMedGoogle Scholar
• 6 LeFlore IC. Misconceptions regarding elective plastic surgery in the black patient. J Natl Med Assoc 1980; 72: 947-948
  PubMedGoogle Scholar
• 7 Alhady SM, Sivanantharajah K. Keloids in various races: a review of 175 cases. Plast Reconstr Surg 1969; 44: 564-566
  CrossrefPubMedGoogle Scholar
• 8 Bayat A, Arscott G, Ollier WE. et al. "Aggressive keloid": a severe variant of familial keloid scarring. J R Soc Med 2003; 96: 554-555
  PubMedGoogle Scholar
• 9 Marneros AG, Norris JE, Watanabe S. et al. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol 2004; 122: 1126-1132
  CrossrefPubMedGoogle Scholar
• 10 Chen Y, Gao JH, Liu XJ. et al. Characteristics of occurrence for Han Chinese familial keloids. Burns 2006; 32: 1052-1059
  CrossrefPubMedGoogle Scholar
• 11 Bella H, Heise M, Yagi KI. et al. A clinical characterization of familial keloid disease in unique African tribes reveals distinct keloid phenotypes. Plast Reconstr Surg 2011; 127: 689-702
  CrossrefPubMedGoogle Scholar
• 12 Ramakrishnan KM, Thomas KP, Sundararajan CR. Study of 1,000 patients with keloids in South India. Plast Reconstr Surg 1974; 53: 276-280
  CrossrefPubMedGoogle Scholar
• 13 Omo-Dare P. Genetic studies on keloid. J Natl Med Assoc 1975; 67: 428-432
  Google Scholar
• 14 Shih B, Bayat A. Genetics of keloid scarring. Arch Dermatol Res 2010; 302: 319-339
  CrossrefPubMedGoogle Scholar
• 15 Stevens CA, Pouncey J, Knowles D. Adults with Rubinstein-Taybi syndrome. Am J Med Genet A 2011; 155A: 1680-1684
  PubMedGoogle Scholar
• 16 Siraganian PA, Rubinstein JH, Miller RW. Keloids and neoplasms in the Rubinstein-Taybi syndrome. Med Pediatr Oncol 1989; 17: 485-491
  PubMedGoogle Scholar
• 17 Petrij F, Giles RH, Dauwerse HG. et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 1995; 376: 348-351
  Google Scholar
• 18 Nadeau A, Kinali M, Main M. et al. Natural history of Ullrich congenital muscular dystrophy. Neurology 2009; 73: 25-31
  CrossrefPubMedGoogle Scholar
• 19 Goeminne L. A new probably X-linked inherited syndrome: congenital muscular torticollis, multiple keloids cryptorchidism and renal dysplasia. Acta Genet Med Gemellol (Roma) 1968; 17: 439-467
  CrossrefPubMedGoogle Scholar
• 20 Sidgwick GP, Bayat A. Extracellular matrix molecules implicated in hypertrophic and keloid scarring. J Eur Acad Dermatol Venereol 2012; 26: 141-152
  CrossrefPubMedGoogle Scholar
• 21 Chalmers RL. The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring. Int Wound J 2011; 8: 218-223
  CrossrefPubMedGoogle Scholar
• 22 Murata H, Zhou L, Ochoa S. et al. TGF-beta3 stimulates and regulates collagen synthesis through TGF-beta1-dependent and independent mechanisms. J Invest Dermatol 1997; 108: 258-262
  CrossrefPubMedGoogle Scholar
• 23 Thompson SA, Canady JW, Coberly DM. et al. Effects of TGFbeta2 on collagen synthesis in cultured normal and wounded fetal mouse palates. Cleft Palate Craniofac J 1999; 36: 425-433
  CrossrefPubMedGoogle Scholar
• 24 Bettinger DA, Yager DR, Diegelmann RF. et al. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 1996; 98: 827-833
  CrossrefPubMedGoogle Scholar
• 25 Peltonen J, Hsiao LL, Jaakkola S. et al. Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. J Invest Dermatol 1991; 97: 240-248
  CrossrefPubMedGoogle Scholar
• 26 Messadi DV, Le A, Berg S. et al. Effect of TGF-beta 1 on PDGF receptors expression in human scar fibroblasts. Front Biosci 1998; 3: a16-a22
  CrossrefPubMedGoogle Scholar
• 27 Fujiwara M, Muragaki Y, Ooshima A. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Arch Dermatol Res 2005; 297: 161-169
  CrossrefPubMedGoogle Scholar
• 28 Gao Z, Wang Z, Shi Y. et al. Modulation of collagen synthesis in keloid fibroblasts by silencing Smad2 with siRNA. Plast Reconstr Surg 2006; 118: 1328-1337
  CrossrefPubMedGoogle Scholar
• 29 Wang Z, Gao Z, Shi Y. et al. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts. J Plast Reconstr Aesthet Surg 2007; 60: 1193-1199
  CrossrefPubMedGoogle Scholar
• 30 Chen Y, Gao JH, Liu XJ. et al. Linkage analysis of keloid susceptibility loci on chromosome 7p11 in a Chinese pedigree. Nan Fang Yi Ke Da Xue Xue Bao 2006; 26: 623-625
  PubMedGoogle Scholar
• 31 Yan X, Gao JH, Chen Y. et al. Preliminary linkage analysis and mapping of keloid susceptibility locus in a Chinese pedigree. Zhonghua Zheng Xing Wai Ke Za Zhi 2007; 23: 32-35
  PubMedGoogle Scholar
• 32 Chen Y, Gao JH, Yan X. et al. Location of predisposing gene for one Han Chinese keloid pedigree. Zhonghua Zheng Xing Wai Ke Za Zhi 2007; 23: 137-140
  PubMedGoogle Scholar
• 33 Bayat A, Bock O, Mrowietz U. et al. Genetic susceptibility to keloid disease and transforming growth factor beta 2 polymorphisms. Br J Plast Surg 2002; 55: 283-286
  CrossrefPubMedGoogle Scholar
• 34 Bayat A, Bock O, Mrowietz U. et al. Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg 2003; 111: 535-543
  CrossrefPubMedGoogle Scholar
• 35 Bayat A, Bock O, Mrowietz U. et al. Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease. Exp Dermatol 2004; 13: 120-124
  CrossrefPubMedGoogle Scholar
• 36 Bayat A, Walter JM, Bock O. et al. Genetic susceptibility to keloid disease: mutation screening of the TGFbeta3 gene. Br J Plast Surg 2005; 58: 914-921
  CrossrefPubMedGoogle Scholar
• 37 Lu WS, Zhang WY, Li Y. et al. Association of HLA-DRB1 alleles with keloids in Chinese Han individuals. Tissue Antigens 2010; 76: 276-281
  CrossrefPubMedGoogle Scholar
• 38 Zhang G, Jiang J, Luo S. et al. Analyses of CDC2L1 gene mutations in keloid tissue. Clin Exp Dermatol 2012; 37: 277-283
  CrossrefPubMedGoogle Scholar
• 39 Brown JJ, Ollier WE, Thomson W. et al. Positive association of HLA-DRB1*15 with keloid disease in Caucasians. Int J Immunogenet 2008; 35: 303-307
  CrossrefPubMedGoogle Scholar
• 40 Yan L, Lu XY, Wang CM. et al. Association between p53 gene codon 72 polymorphism and keloid in Chinese population. Zhonghua Zheng Xing Wai Ke Za Zhi 2007; 23: 428-430
  PubMedGoogle Scholar
• 41 Grainger DJ, Heathcote K, Chiano M. et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999; 8: 93-97
  CrossrefPubMedGoogle Scholar
• 42 Brown JJ, Ollier W, Arscott G. et al. Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro-Caribbeans. Exp Dermatol 2008; 17: 610-613
  CrossrefPubMedGoogle Scholar
• 43 Shih B, Bayat A. Comparative genomic hybridisation analysis of keloid tissue in Caucasians suggests possible involvement of HLA-DRB5 in disease pathogenesis. Arch Dermatol Res 2012; 304: 241-249
  CrossrefPubMedGoogle Scholar
• 44 Nakashima M, Chung S, Takahashi A. et al. A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population. Nat Genet 2010; 42: 768-771
  CrossrefPubMedGoogle Scholar
• 45 Chung S, Nakashima M, Zembutsu H. et al. Possible involvement of NEDD4 in keloid formation; its critical role in fibroblast proliferation and collagen production. Proc Jpn Acad Ser B Phys Biol Sci 2011; 87: 563-573
  CrossrefPubMedGoogle Scholar
• 46 Russell SB, Russell JD, Trupin KM. et al. Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol 2010; 130: 2489-2496
  CrossrefPubMedGoogle Scholar